TW429147B - Pharmaceutical composition for the treatment of CNS disorders - Google Patents
Pharmaceutical composition for the treatment of CNS disordersInfo
- Publication number
- TW429147B TW429147B TW084107281A TW84107281A TW429147B TW 429147 B TW429147 B TW 429147B TW 084107281 A TW084107281 A TW 084107281A TW 84107281 A TW84107281 A TW 84107281A TW 429147 B TW429147 B TW 429147B
- Authority
- TW
- Taiwan
- Prior art keywords
- treatment
- pharmaceutical composition
- cns disorders
- phenyl
- pyrans
- Prior art date
Links
- 208000015114 central nervous system disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 nitro, phenyl Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4429786A DE4429786A1 (de) | 1994-08-23 | 1994-08-23 | Verwendung von substituierten 6-Amino-4H-pyranen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW429147B true TW429147B (en) | 2001-04-11 |
Family
ID=6526290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW084107281A TW429147B (en) | 1994-08-23 | 1995-07-14 | Pharmaceutical composition for the treatment of CNS disorders |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5874462A (zh) |
| EP (1) | EP0777663B1 (zh) |
| JP (1) | JPH10504312A (zh) |
| AT (1) | ATE180478T1 (zh) |
| AU (1) | AU3343995A (zh) |
| CA (1) | CA2198129A1 (zh) |
| DE (2) | DE4429786A1 (zh) |
| DK (1) | DK0777663T3 (zh) |
| ES (1) | ES2131850T3 (zh) |
| GR (1) | GR3030635T3 (zh) |
| IL (1) | IL115004A (zh) |
| MY (1) | MY132090A (zh) |
| TW (1) | TW429147B (zh) |
| WO (1) | WO1996006091A1 (zh) |
| ZA (1) | ZA957015B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19529859A1 (de) * | 1995-08-14 | 1997-02-20 | Bayer Ag | Verwendung von Acyl-substituierten Aminopyranen |
| US8098693B2 (en) * | 2006-05-03 | 2012-01-17 | Himax Technologies Limited | Method of early starting the operation of a descrambler |
| EP3294721A4 (en) | 2015-05-08 | 2018-11-07 | Monash University | 4h-pyran compounds as insulin-regulated aminopeptidase (irap) inhibitors |
| RU2717310C1 (ru) * | 2019-06-04 | 2020-03-20 | Общество с ограниченной ответственностью "Таргет Медикалс" | Ингибиторы альдостеронсинтазы на основе производных 2-амино-4H-пиран-3-карбонитрила |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3981893A (en) * | 1972-07-19 | 1976-09-21 | Bayer Aktiengesellschaft | 2-Amino-4 H-pyrane |
| DE2235406C3 (de) * | 1972-07-19 | 1982-01-07 | Bayer Ag, 5090 Leverkusen | 2-Amino-4H-pyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1994
- 1994-08-23 DE DE4429786A patent/DE4429786A1/de not_active Withdrawn
-
1995
- 1995-07-14 TW TW084107281A patent/TW429147B/zh active
- 1995-08-10 DE DE59506045T patent/DE59506045D1/de not_active Expired - Fee Related
- 1995-08-10 EP EP95929833A patent/EP0777663B1/de not_active Expired - Lifetime
- 1995-08-10 AU AU33439/95A patent/AU3343995A/en not_active Abandoned
- 1995-08-10 ES ES95929833T patent/ES2131850T3/es not_active Expired - Lifetime
- 1995-08-10 AT AT95929833T patent/ATE180478T1/de active
- 1995-08-10 DK DK95929833T patent/DK0777663T3/da active
- 1995-08-10 CA CA002198129A patent/CA2198129A1/en not_active Abandoned
- 1995-08-10 JP JP8507746A patent/JPH10504312A/ja active Pending
- 1995-08-10 WO PCT/EP1995/003168 patent/WO1996006091A1/de active IP Right Grant
- 1995-08-10 US US08/793,068 patent/US5874462A/en not_active Expired - Fee Related
- 1995-08-15 MY MYPI95002394A patent/MY132090A/en unknown
- 1995-08-21 IL IL11500495A patent/IL115004A/xx not_active IP Right Cessation
- 1995-08-22 ZA ZA957015A patent/ZA957015B/xx unknown
-
1999
- 1999-06-30 GR GR990401721T patent/GR3030635T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0777663T3 (da) | 1999-11-22 |
| JPH10504312A (ja) | 1998-04-28 |
| DE4429786A1 (de) | 1996-02-29 |
| ES2131850T3 (es) | 1999-08-01 |
| EP0777663A1 (de) | 1997-06-11 |
| CA2198129A1 (en) | 1996-02-29 |
| AU3343995A (en) | 1996-03-14 |
| ZA957015B (en) | 1996-04-09 |
| DE59506045D1 (de) | 1999-07-01 |
| GR3030635T3 (en) | 1999-10-29 |
| IL115004A0 (en) | 1995-12-08 |
| ATE180478T1 (de) | 1999-06-15 |
| MY132090A (en) | 2007-09-28 |
| IL115004A (en) | 2000-10-31 |
| WO1996006091A1 (de) | 1996-02-29 |
| EP0777663B1 (de) | 1999-05-26 |
| US5874462A (en) | 1999-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9801690D0 (en) | Therapeutic agents | |
| SE0202463D0 (sv) | Novel compounds | |
| DK0771197T3 (da) | Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander | |
| BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
| WO2003106428A8 (fr) | Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine | |
| CA2272291A1 (en) | Crf antagonistic quino- and quinazolines | |
| NO883487D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| SE9903997D0 (sv) | New compounds | |
| SE9803518D0 (sv) | Novel compounds | |
| ATE181731T1 (de) | Isothioharnstoff-derivate als no synthase hemmer | |
| DE69511260D1 (en) | Bicyclische amidinderivate als no-synthetase inhibitoren | |
| DK0843967T3 (da) | Anvendelse af beta-aminopripionsyrederivater som fungicider | |
| SE0302756D0 (sv) | Novel Compounds | |
| MX9702203A (es) | Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida. | |
| DE69402935T2 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
| TW429147B (en) | Pharmaceutical composition for the treatment of CNS disorders | |
| ES2148561T3 (es) | Prevencion y curacion de enfermedades alergicas de tipo i. | |
| GR3033333T3 (en) | Carbamoyl carboxylic acid amides | |
| SE9901901D0 (sv) | Compounds | |
| SE9904676D0 (sv) | Novel compounds | |
| CA2124584A1 (en) | Tetrahydropyridine derivative and cardiotonic agent containing the same as effective component | |
| DK0687257T3 (da) | 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister | |
| SE9802650D0 (sv) | Compounds |